Page last updated: 2024-09-04

lonafarnib and Astrocytoma, Grade IV

lonafarnib has been researched along with Astrocytoma, Grade IV in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Edney, B; Kim, Y; Kondapaneni, RV; Nakod, PS; Rao, SS1
Colman, H; Conrad, C; Gilbert, MR; Groves, M; Hsu, S; Kang, S; Levin, V; Liu, D; Liu, V; Puduvalli, V; Yuan, Y; Yung, WK; Yust-Katz, S1
Glass, TL; Liu, TJ; Yung, WK1
Feldkamp, MM; Guha, A; Lau, N; Roncari, L1

Trials

1 trial(s) available for lonafarnib and Astrocytoma, Grade IV

ArticleYear
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.
    Cancer, 2013, Aug-01, Volume: 119, Issue:15

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Piperidines; Pyridines; Supratentorial Neoplasms; Temozolomide

2013

Other Studies

3 other study(ies) available for lonafarnib and Astrocytoma, Grade IV

ArticleYear
The impact of temozolomide and lonafarnib on the stemness marker expression of glioblastoma cells in multicellular spheroids.
    Biotechnology progress, 2022, Volume: 38, Issue:5

    Topics: Cell Line, Tumor; Dibenzocycloheptenes; Drug Resistance, Neoplasm; Endothelial Cells; Glioblastoma; Humans; Nestin; Piperidines; Pyridines; Spheroids, Cellular; Temozolomide; Tumor Microenvironment

2022
Inhibition of cell growth in human glioblastoma cell lines by farnesyltransferase inhibitor SCH66336.
    Neuro-oncology, 2000, Volume: 2, Issue:3

    Topics: Alkyl and Aryl Transferases; Cell Division; Cell Survival; Enzyme Inhibitors; Farnesyltranstransferase; G2 Phase; Glioblastoma; Humans; Mitogen-Activated Protein Kinases; Piperidines; Pyridines; Tumor Cells, Cultured

2000
Isotype-specific Ras.GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status.
    Cancer research, 2001, Jun-01, Volume: 61, Issue:11

    Topics: Alkyl and Aryl Transferases; Animals; Astrocytoma; Brain Neoplasms; Cell Division; Enzyme Inhibitors; Farnesyltranstransferase; Genes, ras; Glioblastoma; Guanosine Triphosphate; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Monomeric GTP-Binding Proteins; Mutation; Piperidines; Pyridines; ras Proteins; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001